M. Chamson

The BH3-only protein BIM contributes to late-stage involution in the mouse mammary gland

L. Hennighausen, C. Watson, A. Villunger, 2015, Cell Death and Differentiation.

Activated p38-MAPK and gemcitabine sensitivity in recurrent ovarian cancer.

C. Marth, E. Müller-Holzner, A. Zeimet, 2008, Anticancer research.

MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancer.

R. Zeillinger, H. Ulmer, N. Concin, 2011, Oncology reports.

MDM 2 SNP 309 modifies the prognostic significance of the p 53 mutational status in patients with ovarian cancer

R. Zeillinger, H. Ulmer, N. Concin, 2011 .

Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancer

T. Decker, T. Winder, C. Marth, 2013, Journal of Cancer Research and Clinical Oncology.

Clinical Relevance of TAp73 and &Dgr;Np73 Protein Expression in Ovarian Cancer: A Series of 83 Cases and Review of the Literature

R. Zeillinger, H. Uramoto, H. Ulmer, 2011, International Journal of Gynecological Pathology.

Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patients.

T. Decker, T. Winder, C. Marth, 2014, European journal of cancer.